Swiss Drug Giant Roche to Cut 1,000 US Jobs and Close NJ Plant | Business Chief North America
Jean-Jacques Garaud, MD Global Head Pharma ... - Roche
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
COMPANY | Inotrem
Board Of Directors - Inotrem
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Roche, Inotrem extend collaboration on blood test for septic shock | Fierce Biotech
Roche cerrará planta en Estados Unidos
Roche revamps research operations, cuts 1,000 U.S. jobs | Reuters
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Anadys to be acquired by Roche in $230 mln deal | NASDAQ:ANDS
Jean-Jacques Garaud | Nature Reviews Drug Discovery
PharmaBoardroom - Jean-Jacques Garaud - CEO, Inotrem, France
5 September 2011
Roche unterzeichnet Vereinbarung zur Übernahme von Anadys Pharmaceuticals
Roche will close Nutley plant, shed nearly 1,000 jobs - nj.com
Founders – ENYO Pharma
Roche Pays Evotec $10M Up Front in Deal to Develop MAO-B Inhibitor for Alzheimer Disease
Leadership Team - Inotrem
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Plenary lecture by Dr Jean-Jacques Garaud - YouTube
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Roche | Former Members
Inotrem lève 39 millions d'euros pour combattre le choc septique | Les Echos
Roche Diagnostics s'allie à Inotrem contre le choc septique | Les Echos
Roche picks Sanford-Burnham chief to revive lagging research group | Fierce Biotech
